Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Frequently asked questions
What sector does Medistim ASA (MEDI) operate in?
Medistim ASA belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Medistim ASA (MEDI) current stock price?
As of the latest data, Medistim ASA stock price is NOK 308.00, with a previous close of NOK 300.00. Medistim ASA gained NOK 8.00 in the last trading session, representing a 2.67% increase.
What is Medistim ASA (MEDI) current market capitalization?
Medistim ASA market cap is approximately 5.63 billion.
What is Medistim ASA (MEDI) Earnings Per Share (EPS)?
The trailing EPS is NOK 9.75, and the forward EPS is NOK 10.77.
What is Medistim ASA (MEDI) Price-to-Earnings (P/E) ratio?
Medistim ASA current P/E ratio is 31.59, with a forward P/E of 28.6.
What is Medistim ASA (MEDI) EBITDA?
Medistim ASA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 74.98 million.
Does Medistim ASA (MEDI) pay dividends?
Yes. Medistim ASA pays quarterly dividends with an annualized yield of 3.25% and an estimated annual payout of NOK 10.00 per share.
When is the next ex-dividend date for Medistim ASA (MEDI)?
The next ex-dividend date is scheduled for October 27, 2026.
How did Medistim ASA (MEDI) perform in its most recent earnings report?
In the last report (September 30, 2026), Medistim ASA posted an EPS surprise of 28.38% and a revenue surprise of 12.24%.
When is Medistim ASA (MEDI) next earnings report?
Medistim ASA is expected to release its next earnings report on December 31, 2026.
What is Medistim ASA (MEDI) beta (volatility) score?
Medistim ASA has a beta of 0.949, meaning its volatility is roughly in line with the market.
